Skip to content
Group 90
  • Solutions
    • REVEAL
    • Tech Enabled Services
    • flexFS
    • Trusted Research Environment
    • REVEAL
    • Tech Enabled Services
    • flexFS
    • Trusted Research Environment
  • Why P4?
    • Really?
    • Platform
    • Applications
    • Really?
    • Platform
    • Applications
  • resources
    • Posters
    • Blog
    • White papers
    • Case Studies
    • Posters
    • Blog
    • White papers
    • Case Studies
  • About
    • Story
    • Leadership
    • Careers
    • Contact
    • Story
    • Leadership
    • Careers
    • Contact
CONTACT

insideBIGDATA || Big Data in Life Sciences – Why ‘doing things the old way’ is the Biggest Barrier to Progress

Zachary Pitluk, Ph.D., Vice President of Life Sciences and Healthcare at Paradigm4, highlights how real insight comes, not from data collection, but from intelligent data curation, computation, and application.

Bio-IT World || The Role Of Bioinformatics In Bringing Biobanks To The Forefront Of Scientific Breakthroughs

Life science researchers and drug discovery scientists today work in what, in my view, will be remembered in the future as the beginning of a “golden era” where the power of genetic information is connected to a wide range of other healthcare and lifestyle data to support better understanding of disease etiology

Biospace || Paradigm4 Joins the Tetra Partner Network to Leverage Tetra Data into High-performing Analytical Computing Applications for Pharmaceutical Customers

TetraScience, the R&D Data Cloud company, announced today that Paradigm4, an integrated scientific data analytics company, has joined the Tetra Partner Network (TPN) so that pharmaceutical customers can accelerate research decision-making using Tetra Data as a foundation for analytical computing.

International Pharmaceutical Technology | 1 Trillion Cells, 50 Million Individuals

Calculating the true value of scientific data storage platforms is the goal of every developer. With millions of cells to analyze, digital solutions are the key

Pharma’s Almanac | What do you think most differentiates the U.S. pharma/biopharma industry or the market?

Paradigm4’s Marilyn Matz reflects on the understanding complex biological phenomena has required concurrent advances in experimental methods and computing power.

← Previous
Next →
Group 14683
Group 90
Solutions
  • REVEAL
  • Tech Enabled Services
  • flexFS
  • Trusted Research Environment
Why P4?
  • Really?
  • Platform
  • Applications
Resources
  • Posters
  • Blog
  • White Papers
  • Case Studies
About
  • Story
  • Leadership
  • Careers
  • Contact
  • 271 Waverley Oaks Rd, Suite 404 Waltham, MA 02452
  • Privacy Policy
  • Terms of Use
  • Sustainability
  • Biotech Web Design
Group 90
  • Solutions
    • REVEAL
    • TechResearch Environment
    • flexFS
    • Trusted Research Environment
  • Why P4?
    • Really?
    • Platform
    • Tech Stack
    • Collaboration Model
  • Resources
    • Posters
    • Blog
    • White papers
    • Case studies
  • About
    • Story
    • Leadership
    • Careers
    • Contact
CONTACT